+ -0.01
+ 0%
+ 1.76
+ 0.62%
+ 1.99
+ 0.58%

European Parliament Votes On Resolution Supporting Medical Marijuana: Here's What It Means

February 15, 2019 2:30 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Earlier this week, the European Parliament passed a resolution recommending nations in the European Union revise their laws around medical marijuana to better support research and patient access. While non-binding, the resolution does seek to incentivize these revisions, similar to the World Health Organization’s recommendation of a rescheduling of cannabis and several of its key components under international drug treaties.

The resolution called for:

“Member States to address the regulatory, financial and cultural barriers which weigh on scientific research into the use of cannabis for medicinal purposes and on research into cannabis in general; further calls on the Commission and the Member States to define the conditions required to enable creditable, independent scientific research based on a wide range of material to be conducted into the use of cannabis for medicinal purposes.”

What This Means

For Joaquin Rodriguez of GenX Biosciences, this approval has major implications for the global cannabis industry.

“It gives global access to cannabis medicine and opens doors for more research,” said Rodriguez. He believes the resolution could increase global tourism, “in addition to helping remove the global stigma of cannabis being demonized for decades under prohibition… With this action, Europe is well on its way to lift the restrictive policies that have limited the growth of the medical cannabis medical cannabis marketplace.”

Arnaud Dumas de Rauly, co-CEO and co-founder of The Blinc Group, said the resolution represents an important milestone for medical cannabis, and not only for Europe.

“More importantly, we now have a path towards safe and regulated products while defining proper product standards. The next logical step would be a cannabis products directive to solve the regulation disparities across EU member states,” he told Benzinga.

Related Links:

Former Yahoo, Autodesk CEO Carol Bartz Talks Cannabis Space, Caliva Investment: 'It Was Just Obvious'

Scoop: One Of America's Top Pharmaceutical Drug Directories Includes CBD Products For The First Time Ever

Related Articles

Cannabis Brands Get Loud With Rock-Branded Weed Featuring Santana, Jerry Garcia

The list of musicians hawking cannabis products is a long one. Willie Nelson, Margo Price, Snoop Dogg and Berner are just some of the names that come to mind. read more

Cannabis Activity In The Northeast Heats Up With NJ As The Potential Tipping Point

With New Jersey expected to vote on an adult use ballot initiative on Nov. 3, there is a belief that the long-awaited "Green Wave" is upon the Northeast. read more

Cannabis Stocks, Cruise Lines Have A Lot To Gain From A Biden Victory

Heading into Thursday night’s final presidential debate between President Donald Trump and former Vice President Joe Biden, Biden has a commanding lead in most polls and online prediction markets. read more

Exclusive: Cannabis Entrepreneur, NBA Champion John Salley Joins Anthos Group

NBA champion and cannabis entrepreneur John Salley has joined The Anthos Group as the vice president of business development, Benzinga has learned. read more

US Election Could Have 'Positive Collateral Benefits' For Canadian Cannabis Stocks

Cannabis stocks got off to a hit start to the week following a CNBC story published over the weekend suggesting that a Joe Biden victory in the November election could open the door for the decriminalization of adult-use marijuana, potential rescheduling and other federal cannabis l read more